Study Weighs Cost-Effectiveness of CGRP Inhibitors for Migraine
April 20th 2018The Institute for Clinical and Economic Review (ICER) has released a draft evidence report assessing the clinical effectiveness and economic value of calcitonin gene-related peptide (CGRP) inhibitors for the treatment of chronic or episodic migraines.
Read More